Search Results - "Bigelow, George E."

Refine Results
  1. 1

    Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia by Oh, Esther S, Blennow, Kaj, Bigelow, George E, Inouye, Sharon K, Marcantonio, Edward R, Neufeld, Karin J, Rosenberg, Paul B, Troncoso, Juan C, Wang, Nae-Yuh, Zetterberg, Henrik, Sieber, Frederick E, Lyketsos, Constantine G

    Published in PloS one (25-09-2018)
    “…There is strong association of Alzheimer's disease (AD) pathology with gait disorder and falls in older adults without dementia. The goal of the study was to…”
    Get full text
    Journal Article
  2. 2

    Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals by Huhn, Andrew S., Strain, Eric C., Bigelow, George E., Smith, Michael T., Edwards, Robert R., Tompkins, D. Andrew

    Published in Anesthesiology (Philadelphia) (01-01-2019)
    “…WHAT WE ALREADY KNOW ABOUT THIS TOPIC WHAT THIS ARTICLE TELLS US THAT IS NEW BACKGROUND:Managing acute pain in buprenorphine-maintained individuals in…”
    Get full text
    Journal Article
  3. 3

    Extended‐release injectable naltrexone for opioid use disorder: a systematic review by Jarvis, Brantley P., Holtyn, August F., Subramaniam, Shrinidhi, Tompkins, D. Andrew, Oga, Emmanuel A., Bigelow, George E., Silverman, Kenneth

    Published in Addiction (Abingdon, England) (01-07-2018)
    “…Aims To review systematically the published literature on extended‐release naltrexone (XR‐NTX, Vivitrol®), marketed as a once‐per‐month injection product to…”
    Get full text
    Journal Article
  4. 4

    Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers by Mintzer, Miriam Z, Lanier, Ryan K, Lofwall, Michelle R, Bigelow, George E, Strain, Eric C

    Published in Drug and alcohol dependence (01-10-2010)
    “…Abstract Tramadol is an atypical, mixed mechanism analgesic used to treat moderate to severe pain. Based on evidence that tramadol has relatively low abuse…”
    Get full text
    Journal Article
  5. 5

    Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users by Spindle, Tory R., Cone, Edward J., Goffi, Elia, Weerts, Elise M., Mitchell, John M., Winecker, Ruth E., Bigelow, George E., Flegel, Ronald R., Vandrey, Ryan

    Published in Drug and alcohol dependence (01-06-2020)
    “…•Pharmacodynamics were assessed for oral/vaporized CBD and CBD-dominant cannabis.•100 mg vaporized pure cannabidiol (CBD) produced discriminable subjective…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes by Vandrey, Ryan, Herrmann, Evan S, Mitchell, John M, Bigelow, George E, Flegel, Ronald, LoDico, Charles, Cone, Edward J

    Published in Journal of analytical toxicology (01-03-2017)
    “…Most research on cannabis pharmacokinetics has evaluated inhaled cannabis, but oral ("edible") preparations comprise an increasing segment of the cannabis…”
    Get full text
    Journal Article
  7. 7

    A Reinforcement-Based Therapeutic Workplace for the Treatment of Drug Abuse: Three-Year Abstinence Outcomes by Silverman, Kenneth, Svikis, Dace, Wong, Conrad J, Hampton, Jacqueline, Stitzer, Maxine L, Bigelow, George E

    “…Long-term Therapeutic Workplace effects were evaluated in heroin- and cocaine-dependent, unemployed, treatment-resistant young mothers. Participants were paid…”
    Get full text
    Journal Article
  8. 8

    Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid by Spindle, Tory R, Cone, Edward J, Schlienz, Nicolas J, Mitchell, John M, Bigelow, George E, Flegel, Ronald, Hayes, Eugene, Vandrey, Ryan

    Published in Journal of analytical toxicology (01-05-2019)
    “…Currently, an unprecedented number of individuals can legally access cannabis. Vaporization is increasingly popular as a method to self-administer cannabis,…”
    Get full text
    Journal Article
  9. 9

    Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial by Spindle, Tory R, Cone, Edward J, Schlienz, Nicolas J, Mitchell, John M, Bigelow, George E, Flegel, Ronald, Hayes, Eugene, Vandrey, Ryan

    Published in JAMA network open (02-11-2018)
    “…Vaporization is an increasingly popular method for cannabis administration, and policy changes have increased adult access to cannabis drastically. Controlled…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis by Schlienz, Nicolas J., Spindle, Tory R., Cone, Edward J., Herrmann, Evan S., Bigelow, George E., Mitchell, John M., Flegel, Ronald, LoDico, Charles, Vandrey, Ryan

    Published in Drug and alcohol dependence (01-06-2020)
    “…•Pharmacodynamics were assessed for oral cannabis containing 0, 10, 25, and 50 mg THC.•10 mg THC produced discriminable subjective effects but no cognitive…”
    Get full text
    Journal Article
  12. 12

    Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management by Dunn, Kelly E., Barrett, Frederick S., Bigelow, George E.

    Published in Addictive behaviors (01-11-2018)
    “…Opioid-related overdose has increased 137% in the past decade. Training nonmedical bystanders to administer naloxone (Narcan™) is a widely-researched…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis by Spindle, Tory R, Cone, Edward J, Kuntz, David, Mitchell, John M, Bigelow, George E, Flegel, Ronald, Vandrey, Ryan

    Published in Journal of analytical toxicology (07-03-2020)
    “…Abstract Cannabis products in which cannabidiol (CBD) is the primary chemical constituent (CBD-dominant) are increasingly popular and widely available. The…”
    Get full text
    Journal Article
  16. 16

    Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial by Dunn, Kelly E, Tompkins, D Andrew, Bigelow, George E, Strain, Eric C

    Published in JAMA psychiatry (Chicago, Ill.) (01-09-2017)
    “…Opioid use disorder (OUD) is a significant public health problem. Supervised withdrawal (ie, detoxification) from opioids using clonidine or buprenorphine…”
    Get more information
    Journal Article
  17. 17

    Clinical pharmacology of buprenorphine: ceiling effects at high doses by Walsh, S L, Preston, K L, Stitzer, M L, Cone, E J, Bigelow, G E

    Published in Clinical pharmacology and therapeutics (01-05-1994)
    “…The purpose of this study was to characterize the acute effects of buprenorphine, an opioid partial mu-agonist, across a wide range of doses in comparison to…”
    Get more information
    Journal Article
  18. 18

    Opioid Overdose History, Risk Behaviors, and Knowledge in Patients Taking Prescribed Opioids for Chronic Pain by Dunn, Kelly E., Barrett, Frederick S., Fingerhood, Michael, Bigelow, George E.

    Published in Pain medicine (Malden, Mass.) (01-08-2017)
    “…Abstract Objective. More than 100 million adults in the United States experience chronic pain, and prescription opioids are the third most widely prescribed…”
    Get full text
    Journal Article
  19. 19

    Randomized controlled trial of a computerized opioid overdose education intervention by Dunn, Kelly E, Yepez-Laubach, Claudia, Nuzzo, Paul A, Fingerhood, Michael, Kelly, Anne, Berman, Suzan, Bigelow, George E

    Published in Drug and alcohol dependence (01-04-2017)
    “…Highlights • Randomized controlled comparison of three methods to deliver overdose education. • All methods produced knowledge increases that were sustained…”
    Get full text
    Journal Article
  20. 20

    Individual differences in human opioid abuse potential as observed in a human laboratory study by Dunn, Kelly E., Barrett, Frederick S., Brands, Bruna, Marsh, David C., Bigelow, George E.

    Published in Drug and alcohol dependence (01-12-2019)
    “…•Little is known about the differences in how individuals experience opioids.•Study examined differences from 2 opioids, 4 doses, and 2 routes of…”
    Get full text
    Journal Article